← Open Payments lookup

SCOTT ISPIRESCU: Open Payments

NPI 1023148525 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,734 in 62 payments from 16 companies in 2025. Trend: 2023 $2,043 · 2024 $1,183 · 2025 $1,734

Food & beverage: $1,719Travel & lodging: $15
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$254
Axsome Therapeutics, Inc.7$199
E.R. Squibb & Sons, L.L.C.4$193
ABBVIE INC.5$186
Supernus Pharmaceuticals, Inc.7$131
Collegium Pharmaceutical, Inc.6$125
Otsuka America Pharmaceutical, Inc.5$112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$102
Teva Pharmaceuticals USA, Inc.4$99
Vanda Pharmaceuticals Inc.3$81

Products named: INGREZZA, Auvelity, COBENFY, VRAYLAR, REXULTI, Jornay PM, CAPLYTA, UZEDY.

Industry payments across CA — which companies pay providers there.